Remove Inpatient Remove Packaging Remove Pharmaceutical Companies
article thumbnail

A New Pharmaceutical Product | Case Study

PharmaState Academy

Competitive Analysis: Evaluating the market share and brand presence of established pharmaceutical companies and generic drug manufacturers. Distribution Strategy: Establishing partnerships with leading hospital chains, clinics, and diagnostic centers for inpatient and outpatient sales.

article thumbnail

How early planning leads to successful market access and drug launch in Europe

Pharmaceutical Technology

Meanwhile, in Germany, the AMNOG process is conducted twelve months after the drug is launched, thus giving freedom to the company to set the drug’s price during this period. In addition, reimbursement schemes in European countries differ considerably between the outpatient and inpatient sectors.

article thumbnail

Securing every dose with an edible security technology for safe medicines

European Pharmaceutical Review

On- or in-dose authentication means that a security measure or anticounterfeit feature is integrated with the dosage form itself, offering product verification and traceability embedded into each medicine, rather than on the secondary package” WHO estimates that >50 percent of the drugs for sale on the internet are fake.

Dosage 98